Jerzy Gumulka's most recent trade in Cns Pharmaceuticals Inc was a trade of 1,517 Option to purchase common stock done . Disclosure was reported to the exchange on Nov. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cns Pharma Inc | Jerzy Gumulka | Director | 17 Nov 2025 | 1,517 | 1,517 | - | - | Option to purchase common stock | ||
| Cns Pharma Inc | Jerzy Gumulka | Director | 08 Apr 2024 | 17,500 | 147,594 | - | - | Restricted Stock Units | ||
| Cns Pharma Inc | Jerzy Gumulka | Director | 08 Apr 2024 | 17,500 | 129,594 | - | - | Option to purchase common stock | ||
| Cns Pharma Inc | Gumulka Jerzy | Director | 01 Feb 2024 | 33,333 | 112,094 | - | - | Series B Warrant to purchase common stock | ||
| Cns Pharma Inc | Gumulka Jerzy | Director | 01 Feb 2024 | 33,333 | 78,761 | - | - | Series A Warrant to purchase common stock | ||
| Cns Pharma Inc | Gumulka Jerzy | Director | 01 Feb 2024 | 33,333 | 43,006 (0%) | 0% | 0.3 | 10,000 | Common stock | |
| Cns Pharma Inc | Jerzy Gumulka | Director | 19 Apr 2023 | 2,500 | 9,673 (0%) | 0% | 1.7 | 4,250 | Common Stock | |
| Cns Pharma Inc | Jerzy Gumulka | Director | 10 Apr 2023 | 7,173 | 7,173 (0%) | 0% | 0.7 | 5,308 | Common Stock |